Disclose and Manage Conflicts of Interest at Cancer Centers

Roy A. Jensen; Karen E. Knudsen; Leonidas C. Platanias

doi:10.1001/jamainternmed.2019.5542

Disclose and Manage Conflicts of Interest at Cancer Centers

Roy A. Jensen^*, Karen E. Knudsen, Leonidas C. Platanias

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	161
Number of pages	1
Journal	JAMA internal medicine
Volume	180
Issue number	1
DOIs	https://doi.org/10.1001/jamainternmed.2019.5542
State	Published - Jan 2020

Funding

Author Affiliations: Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York. Corresponding Author: Frances R. Levin, MD, New York State Psychiatric Institute, 1051 Riverside Dr, Unit 66, New York, NY 10032 ([email protected]). Conflict of Interest Disclosures: Drs Levin and Mariani report receiving research grants from the National Institutes of Health’s National Institute on Drug Abuse (U54DA03784201 and U01DA045372). 1. Lintzeris N, Bhardwaj A, Mills L, et al; Agonist Replacement for Cannabis Dependence (ARCD) study group. Nabiximols for the treatment of cannabis dependence: a randomized clinical trial. JAMA Intern Med. 2019;179(9):1242-1253. doi:10.1001/jamainternmed.2019.1993 2. Lee DC, Schlienz NJ, Peters EN, et al. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug Alcohol Depend. 2019;194:500-517. doi:10.1016/j. drugalcdep.2018.10.020 3. Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology. 2013;38(8):1557-1565. doi:10.1038/npp.2013.54

ASJC Scopus subject areas

Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamainternmed.2019.5542

Cite this

@article{4f16a963dc8146b79f96bdb641c4b030,

title = "Disclose and Manage Conflicts of Interest at Cancer Centers",

author = "Jensen, {Roy A.} and Knudsen, {Karen E.} and Platanias, {Leonidas C.}",

note = "Funding Information: Author Affiliations: Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York. Corresponding Author: Frances R. Levin, MD, New York State Psychiatric Institute, 1051 Riverside Dr, Unit 66, New York, NY 10032 ([email protected]). Conflict of Interest Disclosures: Drs Levin and Mariani report receiving research grants from the National Institutes of Health{\textquoteright}s National Institute on Drug Abuse (U54DA03784201 and U01DA045372). 1. Lintzeris N, Bhardwaj A, Mills L, et al; Agonist Replacement for Cannabis Dependence (ARCD) study group. Nabiximols for the treatment of cannabis dependence: a randomized clinical trial. JAMA Intern Med. 2019;179(9):1242-1253. doi:10.1001/jamainternmed.2019.1993 2. Lee DC, Schlienz NJ, Peters EN, et al. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug Alcohol Depend. 2019;194:500-517. doi:10.1016/j. drugalcdep.2018.10.020 3. Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology. 2013;38(8):1557-1565. doi:10.1038/npp.2013.54",

year = "2020",

month = jan,

doi = "10.1001/jamainternmed.2019.5542",

language = "English (US)",

volume = "180",

pages = "161",

journal = "JAMA internal medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - Disclose and Manage Conflicts of Interest at Cancer Centers

AU - Jensen, Roy A.

AU - Knudsen, Karen E.

AU - Platanias, Leonidas C.

N1 - Funding Information: Author Affiliations: Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York. Corresponding Author: Frances R. Levin, MD, New York State Psychiatric Institute, 1051 Riverside Dr, Unit 66, New York, NY 10032 ([email protected]). Conflict of Interest Disclosures: Drs Levin and Mariani report receiving research grants from the National Institutes of Health’s National Institute on Drug Abuse (U54DA03784201 and U01DA045372). 1. Lintzeris N, Bhardwaj A, Mills L, et al; Agonist Replacement for Cannabis Dependence (ARCD) study group. Nabiximols for the treatment of cannabis dependence: a randomized clinical trial. JAMA Intern Med. 2019;179(9):1242-1253. doi:10.1001/jamainternmed.2019.1993 2. Lee DC, Schlienz NJ, Peters EN, et al. Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug Alcohol Depend. 2019;194:500-517. doi:10.1016/j. drugalcdep.2018.10.020 3. Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology. 2013;38(8):1557-1565. doi:10.1038/npp.2013.54

PY - 2020/1

Y1 - 2020/1

UR - http://www.scopus.com/inward/record.url?scp=85077480250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077480250&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2019.5542

DO - 10.1001/jamainternmed.2019.5542

M3 - Letter

C2 - 31904783

AN - SCOPUS:85077480250

SN - 2168-6106

VL - 180

SP - 161

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 1

ER -

Disclose and Manage Conflicts of Interest at Cancer Centers

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this